{"id":"W2901155618","doi":"10.1177/1352458518808189","title":"Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital","funders":"Bayer HealthCare; Acorda Therapeutics","keywords":"Ocrelizumab; Medicine; Placebo; Multiple sclerosis; Physical therapy; Internal medicine; Psychiatry; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004029656,0.0009404151,0.001956846,0.0001904574,0.0002593261,0.0008092317,0.0005521539,0.0008613097,0.002092052],"category_scores_gemma":[0.003335192,0.0002733008,0.002503975,0.0003699467,0.0004795438,0.0004138786,0.0002877501,0.001612998,0.0002666408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005958456,"about_ca_system_score_gemma":0.00107073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007521424,"about_ca_topic_score_gemma":0.00192254,"domain_scores_codex":[0.998778,0.0007750969,0.0001122219,0.0001164334,0.0001031227,0.0001149822],"domain_scores_gemma":[0.9976775,0.0007958669,0.0009258038,0.0001462322,0.0001720056,0.0002826667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9173576,0.003871985,0.009773488,0.004418683,0.009241372,0.00009646114,0.0001404304,0.0005693699,0.003778463,0.0001469135,0.001910227,0.04869504],"study_design_scores_gemma":[0.8629748,0.09508272,0.02934394,0.0004390278,0.008410526,0.0001777473,0.00005438635,0.0004131271,0.0007844554,0.0001670323,0.002127772,0.00002442573],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9611117,0.03241444,0.0003516264,0.001108634,0.0002376429,0.001298466,0.001046852,0.00004729432,0.002383338],"genre_scores_gemma":[0.9855547,0.009257881,0.0008000883,0.001041552,0.0002933759,0.001270742,0.0009625306,0.00001268299,0.0008064169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004029656,"threshold_uncertainty_score":0.02131116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05233094733037293,"score_gpt":0.3083775981125121,"score_spread":0.2560466507821392,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}